Participant outcomes—change from baseline adjusted for gender
| Change from baseline OT—control (SE) 95% CI | |||
|---|---|---|---|
| Measure | 2 weeks (n=26) | 3 months (n=23) | 6 months (n=22) |
| BI | 0.7 (1.08) −1.52 to 2.93 | −0.13 (1.33) −2.91 to 2.65 | 0.28 (1.12) −2.06 to 2.61 |
| NEADL | −2.43 (4.59) −11.92 to 7.07 | 3.72 (4.58) −5.83 to 13.27 | 1.58 (5.28) −9.47 to 12.64 |
| EQ5D | 0.06 (0.17) −0.30 to 0.42 | −0.03 (0.15) −0.35 to 0.28 | 0.23 (0.22) −0.23 to 0.69 |
| ASCOT | 0.07 (0.08) −0.09 to 0.23 | 0.06 (0.11) −0.18 to 0.30 | 0.04 (0.10) −0.17 to 0.25 |
| SF-36 PCS | 3.63 (3.38) −3.36 to 10.64 | 1.52 (4.75) −8.43 to 11.47 | 0.09 (5.33) −11.06 to 11.24 |
| SF-36 MCS | 6.60 (4.53) −2.80 to 16.00 | 7.84 (3.17) 1.17 to 14.51* | 3.39 (4.90) −6.88 to 13.66 |
BI, Barthel index, scale: 0–20; NEADL, Nottingham Extended Activities of Daily Living, scale: 0–66; EQ5D, EQ-5D-3L, scale: −0.11 to 1; ASCOT, Adult Social Care Outcomes Toolkit, scale: 0–1; SF-36 PCS, Short-Form 36 Physical Component Summary, scale: 0–100; SF-36 MCS, Short-Form 36 Mental Component Summary, scale: 0–100; MMSE, mini-mental state examination, scale: 0–30.
*One outlier was removed from the analysis of the MCS at 3 months who had an extreme change score of −35.81, which caused a skew of the data.